Information PortalData PortalKnowledge Portal

Data Matrix

Tools & Workflows

Documentation

label:2321 (Glytoucan)

Id:31106fcd-2876-57ea-819c-fe75dccfc985

Glytoucan:G19099PA

Results found

Linked to

	Label	Description
	GLYCOSYLATION.SITE:SITE00001304 CUI has saccharide label:2321 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	GLYCOSYLATION.SITE:SITE00016805 CUI has saccharide label:2321 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	GLYCOSYLATION.SITE:SITE00031867 CUI has saccharide label:2321 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	label:2321 has glycosequence GLYGEN.GLYCOSEQUENCE:G20732FY-GLYCOSEQ00011401 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	label:2321 has canonical residue n-glycan b-d-glcpnac 11 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	label:2321 has glycosequence GLYGEN.GLYCOSEQUENCE:G19099PA-GLYCOSEQ00188264 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	label:2321 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000025 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	GLYCOSYLATION.SITE:SITE00049854 CUI has saccharide label:2321 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	label:2321 has glycosequence GLYGEN.GLYCOSEQUENCE:G79941IJ-GLYCOSEQ00067591 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	label:2321 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000128 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

GLYCOSYLATION.SITE:SITE00001304 CUI has saccharide label:2321

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

GLYCOSYLATION.SITE:SITE00016805 CUI has saccharide label:2321

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

GLYCOSYLATION.SITE:SITE00031867 CUI has saccharide label:2321

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

label:2321 has glycosequence GLYGEN.GLYCOSEQUENCE:G20732FY-GLYCOSEQ00011401 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

label:2321 has canonical residue n-glycan b-d-glcpnac 11

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

label:2321 has glycosequence GLYGEN.GLYCOSEQUENCE:G19099PA-GLYCOSEQ00188264 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

label:2321 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000025 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

GLYCOSYLATION.SITE:SITE00049854 CUI has saccharide label:2321

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

label:2321 has glycosequence GLYGEN.GLYCOSEQUENCE:G79941IJ-GLYCOSEQ00067591 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

label:2321 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000128 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

DISPLAY PER PAGE

Consortium

Community

Resources

@CFDE Workbench 2025

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

Consortium

Community

Resources

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2025

This repository is under review for potential modification in compliance with Administration directives.